Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 5/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP24A1 | Q07973 | 4/20 | 0.46 |
| ▸ | CYP27A1 | Q02318 | 3/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | HTR2B | P41595 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1180262 | 0.87 | ACHE (0.69) | METAP1CYP19A1ACHEALDH1A1HTR2A | |
| SCHEMBL2440274 | 0.84 | CYP24A1 (0.56) | METAP1CYP19A1ACHECYP24A1CYP27A1 | |
| SCHEMBL5241361 | 0.81 | CYP24A1 (0.51) | METAP1CYP19A1ACHECYP24A1CYP27A1 | |
| SCHEMBL23181421 | 0.81 | METAP1 (0.60) | METAP1CYP19A1ACHEALDH1A1CYP24A1 | |
| SCHEMBL316629 | 0.81 | ACHE (0.76) | METAP1CYP19A1ACHEALDH1A1HTR2A | |
| SCHEMBL316628 | 0.80 | METAP1 (0.58) | METAP1CYP19A1ACHEALDH1A1CYP24A1 | |
| SCHEMBL31189156 | 0.80 | METAP1 (0.58) | METAP1CYP19A1ACHEALDH1A1CYP24A1 | |
| SCHEMBL6205297 | 0.80 | CES1 (0.47) | METAP1CYP19A1KDM4E | |
| SCHEMBL9136817 | 0.79 | METAP1 (0.42) | METAP1CYP19A1ACHEALDH1A1CYP24A1 | |
| SCHEMBL29194896 | 0.79 | METAP1 (0.50) | METAP1CYP19A1ACHEALDH1A1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009141096-A1 | SUBSTITUTED SPIRO-ISOXAZOLINES | BAYER CROPSCIENCE AG (DE) | 2009-11-26 | — | — | WO | disclosed |
| US-6528232-B1 | Chemically amplified photoresist composition using the novel sulfonium salt compound as the photoacid generator | NEC CORPORATION (JP) | 2003-03-04 | — | — | US | disclosed |
| EP-1007507-B1 | PROCESS FOR PREPARING 2-CYANOINDAN-1-ONES | BAYER AG (DE) | 2002-11-06 | — | — | EP | disclosed |
| US-6355827-B1 | CYANATION OF HALOINDAN-1-ONE | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-12 | — | — | US | disclosed |
| EP-1007507-A2 | PROCESS FOR PREPARING 2-CYANOINDAN-1-ONES | Bayer Aktiengesellschaft (DE) | 2000-06-14 | — | — | EP | disclosed |
| EP-0752991-B1 | IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS | RHONE POULENC RORER SA (FR) | 1999-05-26 | — | — | EP | disclosed |
| WO-1999010315-A2 | PROCESS FOR PREPARING 2-CYANOINDAN-1-ONES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-03-04 | — | — | WO | disclosed |
| US-5789406-A | Indeno 1,2-E!pyrazine-4-ones, their preparation and the medicaments containing them | RHONE-POULENC RORER S.A. (FR) | 1998-08-04 | — | — | US | disclosed |
| EP-0662971-B1 | 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | RHONE POULENC RORER SA (FR) | 1998-05-13 | — | — | EP | disclosed |
| US-5677306-A | ANTAGONIZING ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTOR, USEFUL FOR TREATING ALL ISCHEMIAS | RHONE-POULENC RORER S.A. (FR) | 1997-10-14 | — | — | US | disclosed |
| EP-0752991-A1 | INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | Aventis Pharma S.A. (FR) | 1997-01-15 | — | — | EP | disclosed |
| WO-1995026349-A1 | INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1995-10-05 | — | — | WO | disclosed |
| EP-0662971-A1 | DERIVATIVES OF 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | Aventis Pharma S.A. (FR) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994007893-A1 | DERIVATIVES OF 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1994-04-14 | — | — | WO | disclosed |
| US-4174397-A | TREATMENT OF OBESITY AND LIPID METABOLISM DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-11-13 | — | — | US | disclosed |